SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 6,684.87 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 788,202.00 |
| Book Value / Share | 1,665.59 |
| Price / Book | n/a |
| NCAV ($M) | 179,260.00 |
| NCAV / Share | 381.59 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.56 |
| Current Ratio | 3.07 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 455,104.00 |
| Assets | 1,064,046.00 |
| Liabilities | 275,844.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 486,871.00 |
| Operating Income | 63,130.00 |
| Net Income | 50,047.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 82,459.00 |
| Cash from Investing | -136,785.00 |
| Cash from Financing | 94,299.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| ODTC – Odonate, Inc. | OMGAQ – Omega Therapeutics, Inc. |
| ONCSQ – OncoSec Medical Incorporated | ORGS – Orgenesis Inc. |
| OTLC – Oncotelic Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io